Boswellic acid inhibits expression of acid sphingomyelinase in intestinal cells

Lipids in Health and Disease

Volumn 8, Issue , 2009, Pages

  Zhang, Yao ^a   Duan, Rui Dong ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3 ACETYL 11 KETO BETA BOSWELLIC ACID; 3 ACETYL BETA BOSWELLIC ACID; ANTIINFLAMMATORY AGENT; BOSWELLIC ACID; KETO BETA BOSWELLIC ACID; MESSENGER RNA; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELIN PHOSPHODIESTERASE INHIBITOR; UNCLASSIFIED DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; TRITERPENE;

ARTICLE; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN CACO 2; CELL STRAIN INT 407; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INTESTINE CELL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BIOSYNTHESIS; CELL LINE; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; INFLAMMATION; INTESTINE;

BOVINAE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CACO-2 CELLS; CELL LINE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INFLAMMATION; INTESTINES; SPHINGOMYELIN PHOSPHODIESTERASE; TRITERPENES;

EID: 72849108236     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-8-51     Document Type: Article

References (33)

1. Biosynthesis of triterpenoid saponins in plants. K Haralampidis M Trojanowska AE Osbourn, Adv Biochem Eng Biotechnol 2002 75 31 49
2. Boswellic acids in chronic inflammatory diseases. HP Ammon, Planta Med 2006 72 12 1100 1116
3. Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. KT Liby MM Yore MB Sporn, Nat Rev Cancer 2007 7 5 357 369
4. Boswellic acids: a group of medicinally important compounds. BA Shah GN Qazi SC Taneja, Nat Prod Rep 2009 26 1 72 89
5. Boswellic acids: biological actions and molecular targets. D Poeckel O Werz, Curr Med Chem 2006 13 28 3359 3369
6. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. H Safayhi T Mack J Sabieraj MI Anazodo LR Subramanian HP Ammon, J Pharmacol Exp Ther 1992 261 3 1143 1146
7. Identification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acids. U Siemoneit B Hofmann N Kather T Lamkemeyer J Madlung L Franke G Schneider J Jauch D Poeckel O Werz, Biochem Pharmacol 2008 75 2 503 513
8. Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-alpha induction in monocytes by direct interaction with IkappaB kinases. T Syrovets B Buchele C Krauss Y Laumonnier T Simmet, J Immunol 2005 174 1 498 506
9. Boswellic acids trigger apoptosis via a pathway dependent on caspase-8 activation but independent on Fas/Fas ligand interaction in colon cancer HT-29 cells. JJ Liu A Nilsson S Oredsson V Badmaev WZ Zhao RD Duan, Carcinogenesis 2002 23 12 2087 2093
10. Compartmentalization of ceramide signaling: physical foundations and biological effects. RN Kolesnick FM Goni A Alonso, J Cell Physiol 2000 184 3 285 300
11. Sphingosine-1-phosphate: an enigmatic signalling lipid. S Spiegel S Milstien, Nat Rev Mol Cell Biol 2003 4 5 397 407
12. Principles of bioactive lipid signalling: lessons from sphingolipids. YA Hannun LM Obeid, Nat Rev Mol Cell Biol 2008 9 2 139 150
13. Metabolism of sphingolipids in the gut and its relation to inflammation and cancer development. RD Duan A Nilsson, Prog Lipid Res 2009 48 1 62 72
14. Acid and neutral sphingomyelinases: roles and mechanisms of regulation. N Marchesini YA Hannun, Biochem Cell Biol 2004 82 1 27 44
15. Alkaline sphingomyelinase: An old enzyme with novel implications. RD Duan, Biochim Biophys Acta 2006 1761 3 281 291
16. Identification of aberrant forms of alkaline sphingomyelinase (NPP7) associated with human liver tumorigenesis. Y Cheng J Wu E Hertervig S Lindgren D Duan A Nilsson RD Duan, Br J Cancer 2007 97 10 1441 1448
17. Occurrence of two molecular forms of human acid sphingomyelinase. K Ferlinz R Hurwitz G Vielhaber K Suzuki K Sandfoff, Biochem J 1994 301 855 862
18. Roles and regulation of secretory and lysosomal acid sphingomyelinase. RW Jenkins D Canals YA Hannun, Cell Signal 2009 21 6 836 846
19. Sphingolipid hydrolyzing enzymes in the gastrointestinal tract. RD Duan A Nilsson, Methods Enzymol 2000 311 276 286
20. Sphingomyelinase and ceramidase in the intestinal tract. R Duan, Eur J Lipid Sci Technol 2007 109 987 993
21. Acetyl-keto-beta-boswellic acid inhibits cellular proliferation through a p21-dependent pathway in colon cancer cells. JJ Liu B Huang SC Hooi, Br J Pharmacol 2006 148 8 1099 1107
22. 3-O-acetyl-11-keto-boswellic acid decreases basal intracellular Ca2+ levels and inhibits agonist-induced Ca2+ mobilization and mitogen-activated protein kinase activation in human monocytic cells. D Poeckel L Tausch S George J Jauch O Werz, J Pharmacol Exp Ther 2006 316 1 224 232
23. LY294002 enhances boswellic acid-induced apoptosis in colon cancer cells. JJ Liu RD Duan, Anticancer Res 2009 29 8 2987 2991
24. Boswellic acid blocks signal transducers and activators of transcription 3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase SHP-1. AB Kunnumakkara AS Nair B Sung MK Pandey BB Aggarwal, Mol Cancer Res 2009 7 1 118 128
25. Acetyl-11-keto-beta-boswellic acid, a constituent of a herbal medicine from Boswellia serrata resin, attenuates experimental ileitis. CF Krieglstein C Anthoni EJ Rijcken M Laukotter HU Spiegel SE Boden S Schweizer H Safayhi N Senninger G Schurmann, Int J Colorectal Dis 2001 16 2 88 95
26. Acid sphingomyelinase inhibition suppresses lipopolysaccharide-mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium-induced colitis in mice. A Sakata T Ochiai H Shimeno S Hikishima T Yokomatsu S Shibuya A Toda R Eyanagi S Soeda, Immunology 2007 122 1 54 64
27. Exogenous sphingomyelinase causes impaired intestinal epithelial barrier function. J Bock G Liebisch J Schweimer G Schmitz G Rogler, World J Gastroenterol 2007 13 39 5217 5225
28. Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: a possible link between inflammatory cytokines and atherogenesis. ML Wong B Xie N Beatini P Phu S Marathe A Johns PW Gold E Hirsch KJ Williams J Licinio I Tabas, Proc Natl Acad Sci USA 2000 97 15 8681 8686
29. Influence of amitriptyline on eryptosis, parasitemia and survival of Plasmodium berghei-infected mice. V Brand S Koka C Lang V Jendrossek SM Huber E Gulbins F Lang, Cell Physiol Biochem 2008 22 5-6 405 412
30. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. V Teichgraber M Ulrich N Endlich J Riethmuller B Wilker CC De Oliveira-Munding AM van Heeckeren ML Barr G von Kurthy KW Schmid M Weller B Tummler F Lang H Grassme G Doring E Gulbins, Nat Med 2008 14 4 382 391
31. Alveolar lipoproteinosis in an acid sphingomyelinase-deficient mouse model of Niemann-Pick disease. M Ikegami R Dhami EH Schuchman, Am J Physiol Lung Cell Mol Physiol 2003 284 3 518 525
32. Permeation of Boswellia extract in the Caco-2 model and possible interactions of its constituents KBA and AKBA with OATP1B3 and MRP2. P Kruger J Kanzer J Hummel G Fricker M Schubert-Zsilavecz M Abdel-Tawab, Eur J Pharm Sci 2009 36 2-3 275 284
33. Metabolism of boswellic acids in vitro and in vivo. P Kruger R Daneshfar GP Eckert J Klein DA Volmer U Bahr WE Muller M Karas M Schubert-Zsilavecz M Abdel-Tawab, Drug Metab Dispos 2008 36 6 1135 1142